PharmARC has expertise in population-based epidemiological study analysis, pharmaco-epidemiological study analysis, feasibility studies for clinical trials, and epidemiology database applications.

We support epidemiology, market research, and outcomes research groups in plugging the epidemiology data gaps they might have with reference to patient-based models, especially in the emerging markets. Through a systematic and cost-effective approach, we identify secondary data and the research publications that provide estimates, and wherever feasible, validate those against other sources and our physician network to deliver evidence-based disease estimates.

Our expertise in secondary desk research includes collection, synthesis and analysis through sources such as Medscape, BMJ, NEJM, Lancet, JAMA, CDC, WHO, Eurostat, Globocan, SEER and other such datasets. Additionally, we have experience in analyzing information from databases such as Da Vinci, Mattson Jack, Datamonitor, Decision Resources and other such client provided sources.

To our credit, we have many publications and posters presented in international conferences on epidemiology and disease burden for multiple therapy areas across geographies.